Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Weiss

Showing results (41-50 of 138) with videos related to

Pageof 14
Sort By:
Journal of Drugs in Dermatology : JDD|March 29, 2012
Treatment of Schamberg's disease with advanced fluorescence technologyDanielle A Manolakos, Jonathan Weiss, Brad Glick, et al.
Autism : the International Journal of Research and Practice|July 2, 2025
Virtual group-based mindfulness for autistic adults: A randomized controlled trialYona Lunsky, Madelaine Carter, Sue Hutton, et al.
Journal of the American Academy of Dermatology|September 23, 2008
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patientsDiane Thiboutot, Andrea Zaenglein, Jonathan Weiss, et al.
Dermatology and Therapy|August 31, 2016
Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 StudiesLeon Kircik, Joseph Fowler, Jonathan Weiss, et al.
American Journal of Clinical Dermatology|March 7, 2016
Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled StudyLinda Stein Gold, Jonathan Weiss, Maria Jose Rueda, et al.
Haematologica|November 1, 2019
Acquisition of the recurrent Gly101Val mutation in <i>BCL2</i> confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (<i>Comment to Tausch et al.</i>)Jonathan Weiss, Martin Peifer, Carmen D Herling, et al.
International Journal of Mental Health and Addiction|April 21, 2017
Access Barriers to Services by Immigrant Mothers of Children with Autism in CanadaNazilla Khanlou, Nasim Haque, Nida Mustafa, et al.
JAMA Dermatology|August 10, 2022
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health RecordsCarla L Zema, Wendell C Valdecantos, Jonathan Weiss, et al.
JAAD Case Reports|August 17, 2021
Rapidly progressive squamous cell carcinoma in a patient with longstanding history of folliculitis decalvansVartan Pahalyants, Nicole S Gunasekera, Reed E Drews, et al.
Regenerative Medicine|September 16, 2011
Genomic instability in cultured stem cells: associated risks and underlying mechanismsAndrew L Ross, Daniel E Leder, Jonathan Weiss, et al.
Pageof 14

Showing results (41-50 of 138) with videos related to

Sort By:
Pageof 14
Journal of Drugs in Dermatology : JDD|March 29, 2012
Treatment of Schamberg's disease with advanced fluorescence technologyDanielle A Manolakos, Jonathan Weiss, Brad Glick, et al.
Autism : the International Journal of Research and Practice|July 2, 2025
Virtual group-based mindfulness for autistic adults: A randomized controlled trialYona Lunsky, Madelaine Carter, Sue Hutton, et al.
Journal of the American Academy of Dermatology|September 23, 2008
An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patientsDiane Thiboutot, Andrea Zaenglein, Jonathan Weiss, et al.
Dermatology and Therapy|August 31, 2016
Efficacy of Secukinumab for Moderate-to-Severe Head and Neck Psoriasis Over 52 Weeks: Pooled Analysis of Four Phase 3 StudiesLeon Kircik, Joseph Fowler, Jonathan Weiss, et al.
American Journal of Clinical Dermatology|March 7, 2016
Moderate and Severe Inflammatory Acne Vulgaris Effectively Treated with Single-Agent Therapy by a New Fixed-Dose Combination Adapalene 0.3 %/Benzoyl Peroxide 2.5 % Gel: A Randomized, Double-Blind, Parallel-Group, Controlled StudyLinda Stein Gold, Jonathan Weiss, Maria Jose Rueda, et al.
Haematologica|November 1, 2019
Acquisition of the recurrent Gly101Val mutation in <i>BCL2</i> confers resistance to venetoclax in patients with progressive chronic lymphocytic leukemia (<i>Comment to Tausch et al.</i>)Jonathan Weiss, Martin Peifer, Carmen D Herling, et al.
International Journal of Mental Health and Addiction|April 21, 2017
Access Barriers to Services by Immigrant Mothers of Children with Autism in CanadaNazilla Khanlou, Nasim Haque, Nida Mustafa, et al.
JAMA Dermatology|August 10, 2022
Understanding Flares in Patients With Generalized Pustular Psoriasis Documented in US Electronic Health RecordsCarla L Zema, Wendell C Valdecantos, Jonathan Weiss, et al.
JAAD Case Reports|August 17, 2021
Rapidly progressive squamous cell carcinoma in a patient with longstanding history of folliculitis decalvansVartan Pahalyants, Nicole S Gunasekera, Reed E Drews, et al.
Regenerative Medicine|September 16, 2011
Genomic instability in cultured stem cells: associated risks and underlying mechanismsAndrew L Ross, Daniel E Leder, Jonathan Weiss, et al.
Pageof 14